Chapter 15- Peptic Ulcer Disease

Description

IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Recognize differences between ulcers induced by Helicobacter pylori (HP) and nonsteroidal anti-inflammatory drugs (NSAIDs) in terms of risk factors, pathogenesis, signs and symptoms, clinical course, and prognosis.
2. Identify desired therapeutic outcomes for patients with HP-associated ulcers and NSAID-induced ulcers.
3. Identify factors that guide selection of an HP eradication regimen and improve compliance with these regimens.
4. Determine the appropriate management for a patient taking a nonselective NSAID who is at high risk for ulcer-related gastrointestinal complications or who develops an ulcer.
5. Devise an algorithm for evaluation and treatment of a patient with signs and symptoms suggestive of an HP-associated or NSAID-induced ulcer.
6. Given patient-specific information and the prescribed drug treatment regimen, formulate a monitoring plan for a patient who is receiving drug therapy to either eradicate HP or to treat an active NSAID-induced ulcer or gastrointestinal complication.

Courses Offered